XDNA
Strategic Trust Kelly CRISPR & Gene Editing Technology ETF
XDNA
XDNA
Delisted
XDNA was delisted on the 30th of November, 2023.
2 hedge funds and large institutions have $279K invested in Strategic Trust Kelly CRISPR & Gene Editing Technology ETF in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
No buyers this quarter
Top Sellers
| 1 |
Jane Street
New York
|
-$1.19M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$14.5K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.65K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $226K | -$14.5K | -1,455 | -6% |
|
|
2
UBS Group
Zurich,
Switzerland
| $53.2K | -$1.65K | -166 | -3% |
|
|
3
Jane Street
New York
| – | -$1.19M | -101,588 | Closed |
|